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Commentary ʹ Programmed death (PD) 1 expressing regulatory T cells in vitiligo  
 
Vitiligo is a common depigmenting skin disease with a prevalence of 1-2%.
1
 The exact 
aetiology and detailed pathogenesis of vitiligo is not fully understood, but destructive CD8
+
 
T cell responses against melanocytes are strongly implicated in the development of the 
disease.
2-3 
Regulatory T cells (Tregs) are a subset of CD4+ lymphocytes that play a key role in 
maintaining peripheral tolerance in vivo through the active suppression of self-reactive T cell 
activation and expansion.
4
 Several studies have reported dysregulation of Tregs in vitiligo 
patients,
5-6
 and repigmentation in a mouse model of spontaneous epidermal 
depigmentation was found to be accompanied by an increased Treg cell infiltration, 
suggesting their importance in preventing an ongoing immune response against 
melanocytes.
7 
 
In this issue of BJD, the findings of Tembhre et al
8 
support a role for Tregs in vitiligo 
pathogenesis. They report a decrease in the frequency of Treg cells and a reduction in the 
expression of Treg cell-associated molecules such as TGF-E, FOXP3 and chemokine receptor 
CCL21 in the peripheral blood and the lesional skin of vitiligo patients. Tregs mediate their 
suppressive function through the programmed death 1 (PD1)/PD1-ligand pathway.
9
 PD1 is 
an inhibitory cell surface molecule that inhibits activation of autoreactive T and B cells, 
suppresses their proliferation, and induces apoptosis on interaction with PD1-ligand on Treg 
cells.
9
 Blocking PD1-ligand in vitro causes the expansion of Tregs suggesting the mechanism 
by which Treg function is contra-regulated on PD1/PD1-ligand engagement.
10
 In the current 
report
8
, the authors observed an increase in the frequency of peripheral PD1+Tregs and 
CD3+CD4+PD1+ T cells in vitiligo patients compared to healthy controls. They hypothesise 
2 
 
that increased expression of PD1 on Treg cells may be acted upon by autoreactive T cells 
expressing PD1-ligand leading eventually to the apoptosis of Tregs and their consequent 
deficiency in vitiligo patients. However, their hypothesis requires much further investigation 
to provide evidence to support it as a mechanism for Treg cell dysfunction in vitiligo. 
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